We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Growthdeck is seeking up to £1 million in funding to capitalize on a positive economic environment and a promising pipeline of opportunities. Despite challenging economic conditions in recent years, the company has outperformed the industry by achieving year-on-year growth in equity fundraising and improving deal flow and quality. With enhanced efficiency and reduced costs, Growthdeck is well-positioned to resume its rapid growth trajectory. Investor interest has rebounded, and the company's increased understanding of investor preferences allows them to identify more suitable deals. Having obtained FCA authorization as a Fund Manager, Growthdeck plans to launch Funds in 2023. The company's objective is to build a business worth over £50 million by 2027, catering to high and ultra-high net worth investors by arranging investments in private companies, backed by a loyal member base. 
days to go: Expired investment: Withheld
Halo Coffee are a range of 100% compostable, biodegradable coffee capsules, containing premium quality coffees which are fully compatible with Nespresso home machines. The capsules have been designed by a world-leading environmental packaging team and are made from a natural blend of paper pulp and bamboo.     
days to go: Expired investment: £656,250
HeadBox are trying to make the process of booking the perfect space for your client or work based event simpler. HeadBox are looking to do this by using their efficient platform to connect guests and hosts directly. Hosts are able to list their space on the platform and guests are able to browse the site to find their ideal space.
days to go: Expired investment: £762,000
HelloDone automates conversations across messaging apps such as WhatsApp, Facebook Messenger, and Instagram for the transportation, home delivery and utility sectors. HelloDone stresses that its Software as a Service (SaaS) enables more than 80% of inbound queries to be resolved automatically between customers of retailers and global carriers. HelloDone states that its portal drastically reduces the customer service burden and creates new dialogues with the customer for enhanced revenues. The company claims that it launched its portal in October 2020 and onboarded its first client in four months, followed by signing large online retailers such as Charles Tyrwhitt and Footasylum. It has also signed contracts with leading UK fast fashion groups and major US retailers. HelloDone is tracking £330,000 worth of Annual Recurring Revenue (ARR) for 2021 and forecasting revenues of £65 million by 2025. They state they will use the investment to arrange flagship brands signed, build on evidence/success metrics and build scale and pace ready for a planned Series-A in mid-2022.
days to go: Expired investment: £700,003
Iceni Labs is an innovative enterprise that develops and deploys cutting-edge technologies to build a safer and secure future. The company takes early-stage technology from the lab to the market by partnering with leading academics, researchers, and commercial experts. It has collaborated with the UK National Health Service’s (NHS) Royal Papworth Hospital to accelerate the development of a non-contact device, SafeScan, that monitors the breathing rate of an individual remotely. Iceni Labs also conducted a one-year clinical study of the device at Royal Papworth Hospital on a sample size of 400 patients. It has been awarded Innovate UK funding to build a prototype for monitoring care home residents. The company's goal is to become globally recognised as a catalyst for successful innovation.
days to go: Expired investment: Withheld
Intoware provide wearable, mobile and desktop technology to SME's and SAS clients. Intoware digitise the deskless workspace and therefore remove the need for paper checklists. Once a checklist is complete, Intoware is able to share the completed list with anyone it may concern.
days to go: Expired investment: £700,000
ITIG have developed software to aid in understanding the investment process, as well as reducing the associated costs of investing. Using their licensed methodologies, retail and institutional investors will see return funds which are more predictable when investing in Exchange Traded Funds (ETFs), resulting in highly diverse and low-cost investment portfolio.
days to go: Expired investment: £67,000
Kaleao has created simple, agile and flexible hardware and software systems which provide 10x more performance per unit of space and consumes 4x less energy. They maintain all promises of the hyperconvergence through the convergence of compute, storage and networking hardware whilst teamed with a full-featured and flexible software platform.
days to go: Expired investment: £2,050,000
Klymat's SaaS business model transforms vehicle fleet management for organizations and fulfills employees' transportation requirements. Through a centralized online platform offered via monthly subscriptions, Klymat empowers businesses to monitor their entire vehicle fleet and employee journeys, regardless of transportation mode. The software computes total business mobility costs and carbon emissions, providing a simpler, more visible, flexible, cost-effective, sustainable, and eco-friendly approach to corporate travel.
days to go: Expired investment: Withheld
Lightpoint Medical is a technology company that is a pioneer in developing and marketing precision-guided cancer surgery. Surgeons aren't able to see if the cancerous tissue has been removed in its entirety or not during a surgery. To better this situation, the company has developed an imaging technology based on PET radiopharmaceuticals, more precisely, Cerenkov Luminescence Imaging (CLI), which helps surgeons to detect cancer in a real-time during surgery. The company's first product has received marketing authorisation, i.e., the CE (European Conformity) Mark. A second product, a laparoscopic device for prostate cancer is in development. A non-clinical device has also been released. For its efforts, Lightpoint Medical won the 'Best in Show' Award at the 2014 MedTech Investing Europe Conference. The company aims to utilise the investment to scale its business.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph